Literature DB >> 15040826

Biochemical markers of bone metabolism and prediction of fracture in elderly women.

Paul Gerdhem1, Kaisa K Ivaska, Sari L Alatalo, Jussi M Halleen, Jukka Hellman, Anders Isaksson, Kim Pettersson, H Kalervo Väänänen, Kristina Akesson, Karl J Obrant.   

Abstract

UNLABELLED: We studied the ability of various markers of bone turnover to predict fracture in 1040 randomly recruited 75-year-old women. A total of 178 of the women sustained at least one fracture during follow-up (mean, 4.6 years). In elderly women, TRACP5b and urinary fragments of osteocalcin are promising new markers for prediction of fracture, in particular, vertebral fracture.
INTRODUCTION: Biochemical markers reflecting bone turnover may improve the prediction of fractures.
MATERIALS AND METHODS: The ability of 10 markers of bone turnover to predict fracture in 1040 elderly women in the Malmö OPRA study was studied. Serum bone-specific alkaline phosphatase and four different forms of serum osteocalcin (S-OC) were analyzed as markers of bone formation and serum C-terminal cross-linking telopeptides of type I collagen (S-CTX), serum TRACP isoform 5b (S-TRACP5b) and urinary free deoxypyridinoline (U-DPD) as markers of bone resorption. Two novel assays for osteocalcin fragments in urine (U-OC) were analyzed. Areal BMD (aBMD) was measured by DXA in the femoral neck and lumbar spine.
RESULTS: In total, 231 fractures were sustained by 178 of the women during a 3- to 6.5-year (mean, 4.6 years) follow-up period. When women with prospective fractures were compared with women without fractures, S-TRACP5b, S-CTX, one S-OC, and one U-OC were higher in women with a fracture of any type (all p < 0.05), and all bone markers were higher in women with clinical vertebral fracture (all p < 0.05). Markers were not significantly elevated in women with hip fracture. When women within the highest quartile of a bone marker were compared with all others, S-TRACP5b and one U-OC predicted the occurrence of a fracture of any type (odds ratio [OR]), 1.55 and 1.53; p < 0.05). S-TRACP5b, the two U-OCs, and S-CTX predicted vertebral fracture (OR, 2.28, 2.75, 2.71, and 1.94, respectively; all p < 0.05), and the predictive value remained significant for S-TRACP5b and the two U-OCs after adjusting for aBMD (OR, 2.02-2.25; p < 0.05). Bone markers were not able to predict hip fracture.
CONCLUSION: These results show that biochemical markers of bone turnover can predict fracture, and in particular, fractures that engage trabecular bone. S-TRACP5b and U-OC are promising new markers for prediction of fracture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15040826     DOI: 10.1359/JBMR.0301244

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  66 in total

Review 1.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 2.  Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.

Authors:  Serge Cremers; Patrick Garnero
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice.

Authors:  D J Leeming; P Alexandersen; M A Karsdal; P Qvist; S Schaller; L B Tankó
Journal:  Eur J Clin Pharmacol       Date:  2006-08-16       Impact factor: 2.953

4.  Prediction of bone loss using biochemical markers of bone turnover.

Authors:  J Lenora; K K Ivaska; K J Obrant; P Gerdhem
Journal:  Osteoporos Int       Date:  2007-04-18       Impact factor: 4.507

5.  Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.

Authors:  Mary L Bouxsein; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

6.  Bone turnover markers are correlated with quantitative ultrasound of the calcaneus: 5-year longitudinal data.

Authors:  J Lenora; P Gerdhem; K J Obrant; K K Ivaska
Journal:  Osteoporos Int       Date:  2008-10-23       Impact factor: 4.507

7.  Effects of alfacalcidol alone or in combination with elcatonin on incidence of osteoporotic vertebral fractures in postmenopausal women with spondylosis.

Authors:  Naohisa Miyakoshi; Yoichi Shimada; Shigeru Ando; Takashi Minato; Eiji Itoi
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  Distribution of serum βCTX in a population-based study of postmenopausal women taking into account different anti-osteoporotic therapies (the FRODOS Cohort).

Authors:  Eduardo Kanterewicz; Pilar Peris; Emma Puigoriol; Aina Yáñez; Pau Rosique; Luis Del Rio
Journal:  J Bone Miner Metab       Date:  2012-12-08       Impact factor: 2.626

Review 9.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:  Matthew B Greenblatt; Joy N Tsai; Marc N Wein
Journal:  Clin Chem       Date:  2016-12-09       Impact factor: 8.327

10.  Incidence and risk factors for osteoporotic vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The São Paulo Ageing & Health (SPAH) Study.

Authors:  D S Domiciano; L G Machado; J B Lopes; C P Figueiredo; V F Caparbo; L Takayama; R M Oliveira; P R Menezes; R M R Pereira
Journal:  Osteoporos Int       Date:  2014-08-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.